Homologous defective interfering (DI) particles protected adult Syrian hamsters against lethal systemic infection with vesicular stomatitis virus (VSV) serotype Indiana. The DI particles had to be biologically active, but did not have to be administered at the same inoculation site as the infectious virus. Serum and tissue levels of VSV postinoculation were significantly lower in DI-protected animals than in unprotected controls, suggesting that true autointerference was occurring. However, some aspects of protection also must be mediated through nonspecific mechanisms, since susceptible hamsters could be protected against VSV Indiana by coinjection with heterologous DI particles prepared from VSV serotype New Jersey or by simultaneous administration of polyinosinic acidpolycytidylic acid. By measuring serum levels of putative hamster interferon (type 1), we found that animals coinjected with VSV and DI particles or polyinosinic acid-polycytidylic acid produced significant levels of interferon. Since similarly high serum levels of interferon were measured in recipients of VSV alone (animals that eventually died from infection), there appeared to be no correlation between protection against lethal disease and induced levels of serum interferon. Instead, serum interferon levels correlated positively with amounts of VSV PFU found in serum and tissues of infected animals, the lowest levels being found in serum of animals protected with homologous DI particles. The data are consistent with the hypothesis that autointerference by DI particles as well as various host defense mechanisms (possibly including induction of interferon) participates in protecting hamsters against lethal VSV infection.
Homologous defective interfering (DI) particles protected adult Syrian hamsters against lethal systemic infection with vesicular stomatitis virus (VSV) serotype Indiana. The DI particles had to be biologically active, but did not have to be administered at the same inoculation site as the infectious virus. Serum and tissue levels of VSV postinoculation were significantly lower in DI-protected animals than in unprotected controls, suggesting that true autointerference was occurring. However, some aspects of protection also must be mediated through nonspecific mechanisms, since susceptible hamsters could be protected against VSV Indiana by coinjection with heterologous DI particles prepared from VSV serotype New Jersey or by simultaneous administration of polyinosinic acidpolycytidylic acid. By measuring serum levels of putative hamster interferon (type 1) , we found that animals coinjected with VSV and DI particles or polyinosinic acid-polycytidylic acid produced significant levels of interferon. Since similarly high serum levels of interferon were measured in recipients of VSV alone (animals that eventually died from infection), there appeared to be no correlation between protection against lethal disease and induced levels of serum interferon. Instead, serum interferon levels correlated positively with amounts of VSV PFU found in serum and tissues of infected animals, the lowest levels being found in serum of animals protected with homologous DI particles. The data are consistent with the hypothesis that autointerference by DI particles as well as various host defense mechanisms (possibly including induction of interferon) participates in protecting hamsters against lethal VSV infection.
A physiological role for defective interfering (DI) particles in in vivo viral infections has been postulated (14) and has been studied with several viruses by using mice or rats as hosts. Studies with standard virus and DI particles have been conducted with vesicular stomatitis virus (VSV) (6, 8) , influenza virus (24) , reovirus (26) , lymphocytic choriomeningitis virus (22, 27) , Semliki Forest virus (7), and rabies virus (4) . These studies had two common factors. First, viral administration was either intracerebral (i.c.) or intranasal, resulting in infections of the central nervous system. None of the studies involved the effects of DI particles on systemic viral infections. Second, interferon was considered not to play an important role in the observed prolonged survival or decreased viral titers in infected tissues after concomitant inoculation of wild-type virus and DI particles, since no interferon-like activity could be demonstrated.
One model system for studying the prophylactic effects of DI particles is the lethal infection of mice after i.c. injection of VSV; however, using this system, different investigators have reported contradictory results. Holland and co-workers (8, 16) have shown that simultaneous i.c. injection of VSV and large numbers of highly purified homologous DI particles can provide complete protection or significant prolongation of life. This protection was shown to require biologically active DI particles, to be specific for homologous virus, and to be unrelated to the action of interferon. In contrast, Crick and Brown (6), using a similar experimental system, found that biological activity is not a prerequisite and that protection by DI particles is not specific; i.e., they found that chemically inactivated DI particles can protect against both homologous and heterologous VSV challenge. They concluded that DI particles enlist a host mechanism, probably immunological, and that most of the observed protection is not due to true ho-mologous interference. Both groups of investigators, however, agree that induction of and concomitant antiviral activity due to interferon are not important components of DI particle protection in vivo.
We have developed a model for studying the prophylactic effects of DI particles on a lethal systemic disease; this model is not confined to the restricted environment of the central nervous system and allows for potential interaction of host defense systems. Our model uses adult Syrian hamsters and VSV serotype Indiana (VSVIND). We have reported (9) that VSV causes a lethal systemic infection in certain inbred strains of Syrian hamsters after intraperitoneal (i.p.) inoculation of the virus. Death of infected hamsters occurs within 72 h, and histological studies (10) Viruses. VSVIND has been described previously (5) . Two homologous VSVIND DI particles were used: DI-2 (VSI ts+ ATCC DI 0.54), a DI from the 5' end of the VSV genome (17) and DI-LT (VSI HR ATCC DI 0.67), a long DI from the 3' end of the genome of a heatresistant VSVIND variant (23 
Injection of poly(I)-poly(C). Poly(I)-poly(C) (P-L
Biochemicals, Inc.), a known inducer of interferon, was diluted in phosphate-buffered saline to a concentration of 1 mg/ml. Poly(I)-poly(C) (100 ,ug/100 g of body weight) was injected i.p. at either 24 h before or immediately before injection of virus.
Interferon assays. Antiviral activity in sera obtained from infected hamsters was measured by plaque reduction of VSVNJ or VSVIND on HaK cells (hamster kidney fibroblasts) that were obtained from Paul Glesen. Briefly, hamsters were bled by cardiac puncture at various times after injection of virus; serum was prepared from whole blood and stored at -70°C.
Before assay, the serum was diluted 1:4 in Dulbecco modified minimal essential medium, centrifuged at 100,000 x g for 90 min, and then subjected to UV irradiation for 15 min. Aliquots (1 ml) of twofold serial dilutions of irradiated serum in Dulbecco modified minimal essential medium containing 5% neonatal calf serum were added to replicate monolayers of HaK cells in 35-mm petri dishes. After 20 h of incubation at 37°C, the test samples were aspirated, the cells were washed once with phosphate-buffered saline, and 50 to 100 PFU of the test virus was added in a volume of 0.1 ml. After 1 h at 37°C to allow for virus adsorption, 2.5 ml of 0.9o noble agar in Dulbecco modified minimal essential medium plus 5% neonatal calf serum was added. Plaques were counted 2 days later. Interferon titers are expressed as the reciprocal of the dilution giving a 50% reduction in viral plaques. Statstical analyses. The significance of the data (P values) was determined by using the standard normal distribution for differences between sample proportions.
RESULTS
Effects of homologous DI particles on lethal VSV infection. We first determined whether homologous DI particles, which are capable of in vitro interference (17, 23) , could provide protection from lethal systemic infections caused by i.p.-injected VSV. Table 1 shows the effects of coinjecting either DI-2 or DI-LT with wild-type VSVIND. Significant protection (>75% survival) was achieved at DI-2/VSV ratios of 106:1 and 105:1, whereas at ratios of 104:1 and lower, the majority of the recipient hamsters died. Similarly, when another homologous DI particle, DI-LT, was coinjected with VSV, 100% of hamsters that received doses of 106:1 and 105:1 survived, and at the lowest dose of 103:1, 50% of the recipient hamsters survived. Thus, both homologous DI particles could protect LSH hamsters from death. In this and subsequent experiments, more than 65% of the animals that died did so on days 2 or 3 postinjection. No animal died more than 12 days after injection of virus. The fact that DI-LT appeared to be more effective than DI-2 at lower ratios of DI particles to VSV may imply that the stock preparation of DI-LT contained more biologically active DI particles. Alternatively, if protection was not due to true interference, then DI-LT may be more efficient than DI-2 at eliciting one or more protective host defense mechanisms.
Serum and tissue homogenates from LSH hamsters that had previously received VSV and DI particles at various times were tested for PFU by plaque assay. PFU were detected in 8 of 26 hamsters tested up to 48-h postinfection (see Fig. 3 ). In serum from only one animal were PFU detected at more than 32 h after infection. The distribution of PFU in 10-fold serial dilutions of individual samples suggested that DI particles were present and were interfering with the assay. This implies that DI particles are replicated in the hamster and can interfere with standard virus production at sites distant from the site of virus and DI particle inoculation.
Effects of UV-inactivated DI particles on lethal VSV infection. Whether inactivated DI particles can protect against i.c. infection of mice with VSV is not certain since the results of Jones and Holland (16) and of Crick and Brown (6) are contradictory. To test whether inactive DI particles can protect in the VSV-hamster system, comparable amounts of DI-2 or UV-inactivated DI-2 were mixed with VSV and injected i.p. into separate groups of hamsters. A third group received VSV mixed with 3 x 109 PFU equivalents of UV-inactivated VSV. The survival data for animals in these and control groups are shown in Table 2 . The majority of hamsters that received VSV only, VSV plus UV-inactivated DI-2, or VSV plus UV-inactivated VSV died. In comparison, hamsters that received untreated DI-2 plus VSV showed a significantly higher percentage of survivors. These results agree with the data of Jones and Holland (16) in that biologically active DI particles were necessary for prophylaxis and suggest that specific interference occurred. It has been shown by others (1; Horodyski and Holland, unpublished data) that UV inactivation of DI particles destroys their ability to interfere in vitro. (Table 3) . Coinfection of hamsters with VSVIND and DI-NJ revealed that 79% of hamsters receiving heterologous DI-NJ survived the infection (Table 4) . We conclude, therefore, that the prophylactic effect of DI particles in systemic VSV infections in hamsters may occur through a mechanism that is not true interference. Effect of poly(I)-poly(C) on lethal VSV infection. Although protection by heterologous DI particles did not exclude the possibility that true interference was achieved by homologous DI particles in vivo, it strongly implicated another mechanism, possibly interferon. DI particles are known to be more efficient at inducing interferon than is wild-type VSV, which is highly cytopathic. The possible role of interferon in attenuation of lethal VSV disease was tested by i.p. coinjections of LSH hamsters with VSV and poly(I)-poly(C), an agent known to induce interferon (Table 5 ). More than 80% of hamsters that received poly(I)-poly(C) either 24 h before or at the same time as VSV survived the infection, irrespective of whether a small or large dose of virus was coadministered. In addition, 100 ,ug of poly(I)-poly(C) per 100 g of body weight appeared to be sufficient to elicit maximal protection, since a three-times-greater amount of poly(I)-poly(C) resulted in the same percentage of hamsters surviving 104 PFU of VSV. These results are consistent with the hypothesis that interferon induced by homologous and heterologous DI particles protects susceptible hamsters from lethal VSV infections. The following studies were designed to determine the extent to which Syrian hamsters can and do produce interferon in response to VSV, DI particles, poly(I)-poly(C), or a combination of these.
Production of interferon after iuJection of poly(I)-poly(C). The ability of hamsters as a species to produce interferon in response to poly(I)-poly(C) has been questioned by at least two investigators (18, 21) , although others (15, 25) have shown measureable interferon in serum, decreased viral titers in tissues, or both after i.p. injection of poly(I)-poly(C). We therefore tested the ability of 100 ,ug of poly(I)-poly(C) administered i.p. to elicit interferon production in LSH (Fig. 1) . Sera from eight uninjected LSH hamsters had no detectable interferon activity (titer, <2).
Levels of serum interferon after in,jection of VSV alone, with DI particles, or with poly(I)-poly(C). To determine whether interferon participates in DI particle-mediated protection against lethal VSV infection, we looked at serum inter- substantial amounts of interferon were generated in hamsters (Fig. 2) . It is evident that levels of serum interferon do not correlate with protection from lethal VSV infection, since injection of VSV alone resulted in levels of interferon equivalent to those found in animals that received VSV plus poly(I)-poly(C) and greater than those found in animals that received VSV plus DI particles. We thus conclude that either serum interferon levels are an insufficient index of tissue interferon that successfully protects hamsters from VSV, or interferon production is not a critical factor in protection.
The numbers of PFU of VSV present in sera that were tested for interferon activity were determined by plaque assay before high-speed centrifugation and UV treatment of the sera. Viral PFUs as a function of interferon titers for individual animals from which serum was obtained at 24 to 48 h postinfection are plotted in Fig. 3 . The data indicate that there is some correlation between serum interferon levels and PFU of VSV. It also can be seen that maximum serum titers of 107 to 108 PFU/ml were attained in animals that received VSV alone or VSV plus poly(I)-poly(C). These results indicate that the mechanism of protection in hamsters treated with poly(I)-poly(C) is not inhibition of virus replication. It also should be noted that of the 16 hamsters that received VSV plus DI particles, only 5 had measureable PFU whereas all had measureable levels of interferon.
Since maximum interferon titers of 6,000 to 7,000 U/ml of serum were obtained from hamsters injected with VSV, this virus appears to be an efficient inducer of interferon in Syrian hamsters, even in hamsters susceptible to the acute, lethal disease.
Characterization of VSV-induced interferon. Identical titers of interferon were found in all cases when both VSVIND and VSVNJ were used as test viruses. This indicated that anti-VSVIND antibodies, if present in sera from infected ham- sters, did not interfere with the assay. It has been shown (3) that antibodies directed against VSVIND do not cross-react with VSVNJ. We confirmed this by using VSV-immune sera from rabbits and hamsters (data not shown). Anti-VSVIND serum that completely neutralized VSVIND at a 1:2,000 dilution did not neutralize VSVNJ at a 1:10 dilution. To confirm further that anti-VSV antibodies were not responsible for the reduction in the numbers of plaques seen in interferon assays, hamster sera containing various amounts of interferon, as determined on HaK cells, were tested on mouse L cells; no reduction in VSVIND or VSVNJ plaques were seen on L cells, whereas the titers were the same for both viruses on HaK cells. These results indicate that anti-VSV antibodies were not responsible for the antiviral activity and also illus- trate the species specificity of interferon induced in hamsters after VSV infection.
The antiviral activity present was assumed to be type I interferon since it met the following criteria: (i) specific for the species of origin; (ii) nonspecific for viruses; (iii) active after centrifugation at 100,000 x g; (iv) active after UV irradiation; (v) sensitive to trypsin; and (vi) resistant to pH 2 (data not shown).
DISCUSSION
To our knowledge, these experiments are the first to examine the protective effects of DI particles on a systemic viral infection. In Syrian hamsters DI particles obviously were very effective in preventing the fatal disease that normally follows i.p. injection of VSV. The observed protection, however, probably was not due solely to true autointerference since heterologous as well as homologous DI particles and poly(I)-poly(C) protected against death. Interferon probably plays a role in DI-induced protection of hamsters; however, since high levels of serum interferon were achieved in hamsters that received only VSV (and that ultimately died from infection), interferon production alone, as measured by serum levels, is insufficient to account for the protective effect.
It is likely that the different protective treatments elicit different host defense mechanisms. Table 6 summarizes the effects of the prophylactic treatments of VSV-infected hamsters with respect to protection, interferon, and viremia. Although there was an obvious correlation between viremia and interferon levels, there was no correlation between protection and serum interferon concentrations. The lack of detectable PFU in serum and tissues of animals protected by homologous DI particles suggests that in vivo autointerference may have been occurring. It has been suggested (16) , however, that autointerference may not be the only effect of DI particles. This is supported by our findings (i) that intravenous injections of DI particles protected against lethal i.p. injections of VSV and (ii) that heterologous DI-NJ protected against lethal VSVIND infections.
In similar studies with mice inoculated i.c., other investigators (6, 8) detected little or no interferon in the central nervous system after coinfection with virus and DI particles, possibly due to poor interferon production in the central nervous system. Perhaps the best mechanism to provide for early protection after i.c. infection of mice with VSV is true interference, and, to be effective, this requires large numbers of DI particles to insure coinfection of all cells. This idea is supported by the fact that Doyle and Holland (8) had to use extremely large ratios of DI particles to VSV (more than 1,000-fold higher than we used to protect hamsters) to observe protection in the murine model. Gresser et al. (11) have shown, however, that potent interferon preparations administered after the onset of VSV replication in brains of infected mice can provide some protection from death.
Irrespective of the participation of interferon in the outcome (i.e., death or survival) of VSV infection of hamsters, it probably does limit the final amount of infectious VSV produced. It has been demonstrated (20) that interferon-treated cells produce VSV progeny that are less infectious than those produced in normal cells. The concordant rise and fall of VSV PFU in sera and tissues (10) and of serum interferon levels (Fig.  2) support this idea. The data we obtained after VSV infection of hamsters closely resembles that of Bradish and Titmuss (2), who followed the same parameters in mice injected i.p. with Semliki Forest virus; however, their finding that prophylactic administration of fungal doublestranded RNA influenced the extent of viral replication but did not alter virulence is in contrast to our findings.
Another possible effect of injection of poly(I)-poly(C) is that it alters the primary site of VSV replication in hamsters. After i.p. injection of the virus, the first round of VSV replication probably occurs in peritoneal macrophages with subsequent systemic spread of the virus. Since poly(I)-poly(C) induces macrophages to produce interferon (13) , and since interferon-treated macrophages do not support VSV replication as well as do untreated macrophages (12) , the bulk of VSV replication may be shifted to other tissues or cell types in poly(I)-poly(C)-treated hamsters. Protection also could be achieved The facile detection of interferon in serum of hamsters treated with poly(I)-poly(C) or injected with VSV alone deserves mention. Hamsters are generally considered to be inefficient producers of interferon, especially after treatment with poly(I)-poly(C). The results presented in this paper prove that hamsters do make substantial amounts of interferon.
Our results show that a number of factors can be involved in early protection of hamsters against acute systemic VSV infection.
